Lamothe Jeffrey G. 4
4 · Aptevo Therapeutics Inc. · Filed Jan 30, 2024
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2024-01-28+1,833→ 28,337 total - Exercise/Conversion
Restricted Stock Unit
2024-01-28−1,833→ 0 total→ Common Stock (1,833 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022.